3SBio Inc. to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference

SHENYANG, China, May 28 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, announces that David Chen, Chief Operating Officer, and Kevin Teo, Chief Financial Officer will present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference in Dana Point, California on Tuesday, June 10, 2008 at 1:20 PM (Pacific Time).

The presentation will be webcast live and can be accessed on the Webcasts section of the investors page of the 3SBio website at: http://bbs.3sbio.com/en/News/ShowInfo_nnn6.aspx?ID=65 . A replay of the presentation and accompanying slides will be available on the 3SBio website for a period of 30 days.

About 3SBio Inc.

3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China.

For more information, please visit 3SBio on the web at: http://www.3sbio.com .

For more information, please contact:

Investor Contact:

Kevin Teo, CFO

3SBio Inc.

Tel: +86-24-2581-1820

Investor Relations (US):

Mahmoud Siddig

Taylor Rafferty

Tel: +1-212-889-4350

Investor Relations (HK):

Ruby Yim

Taylor Rafferty

Tel: +852-3196-3712

Media Contact:

Jason Marshall

Taylor Rafferty

Tel: +1-212-889-4350